These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 401388)

  • 1. [Chemotherapy of cancer of the breast].
    de la Garza Salazar JG
    Ginecol Obstet Mex; 1977 Oct; 42(252):237-45. PubMed ID: 401388
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternating versus sequential therapy in advanced breast cancer.
    Romero A; Rabinovich MG; Pérez JE; Macchiavelli M; Leone BA; Strauss E; Goldar D; Alvarez LA; Vallejo C
    Medicina (B Aires); 1987; 47(3):243-8. PubMed ID: 3326994
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen.
    Aksoy S; Harputluoglu H; Guler N; Altundag K; Hayran M; Tekuzman G; Ozisik Y
    Breast J; 2007; 13(4):431-2. PubMed ID: 17593056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adriamycin--breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1911-5. PubMed ID: 8978796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of breast cancer.
    Cooper RG
    Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
    [No Abstract]   [Full Text] [Related]  

  • 6. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group phase II trial.
    Vogel CL; Raney M; Carpenter J
    Cancer Treat Rep; 1987 Dec; 71(12):1271-3. PubMed ID: 3690536
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of metastatic breast cancer].
    Yahalom J; Biran S; Sulkes A
    Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of disseminated forms of breast cancer using platinum derivatives].
    Gorbunova VA; Trofimova NB; Manziuk LV
    Vopr Onkol; 1990; 36(4):455-7. PubMed ID: 2345995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of locally advanced cancer of the breast].
    Lluch A; Pascual A; Cervantes A; Antón A; Martínez Agulló A; Aviñó J; Alberola V; García-Conde J
    Med Clin (Barc); 1987 May; 89(1):7-10. PubMed ID: 3613742
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of adjuvant chemotherapy for breast cancer in a community practice.
    Rosenberg A; Winer EP; Cadman E
    Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adriamycin/cyclophosphamide: current standard in the adjuvant therapy of breast carcinoma? Or: how should one really put this question?].
    Cavalli F
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1882-4. PubMed ID: 7973514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adriamycin/cyclophosphamide: current standard in adjuvant therapy for breast carcinoma?].
    Sauter C
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1879-81. PubMed ID: 7973513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients].
    Toi M; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2057-60. PubMed ID: 8085859
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer].
    Abe O; Tominaga T; Enomoto K; Abe R; Iino Y; Koyama H; Fujimoto M; Nomura Y; Tanaka T
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2160-8. PubMed ID: 3717960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.
    Coccaro M; Gallucci G
    J Clin Oncol; 2008 Jul; 26(19):3288; author reply 3289. PubMed ID: 18591567
    [No Abstract]   [Full Text] [Related]  

  • 18. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
    Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
    Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 20. Amelioration of doxorubicin cardiotoxicity by the bispiperazinedione ICRF-187 in women with advanced breast cancer: a preliminary report.
    Jurga L; Misurová E; Vancík J
    Neoplasma; 1993; 40(4):259-62. PubMed ID: 8272153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.